Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > mdjbrown...I don't understand "mystery partner named as
View:
Post by subaru1i on Apr 05, 2024 12:05pm

mdjbrown...I don't understand "mystery partner named as

defendant".    All the court documents are in the public realm including all named defendants so how can a defendant's name be a mystery?...that's the part of your post I don't understand.  Could you put a little more color on that for me please.
Comment by mdjbrown on Apr 05, 2024 1:18pm
s1i, all defendants are named in the lawsuit, however the defendant that partnered with Medipharm has not been identified to date. The obvious choice due to national ties would be Apotex, but that has not been confirmed by Labs. "In partnership with a large global pharmaceutical company, in Q3 MediPharm contributed API to an Abbreviated New Drug Application filed with the US Food and Drug ...more  
Comment by alleyesonme on Apr 05, 2024 1:50pm
What do all defendants but one have in common?...an FDA approved facility for the production of cannabidol a.k.a CBD a.k.a epidiolex...to my knowledge no one but labs and Jazz can supply CBD API for the U.S pharmaceutical market.$$$$$$$$$
Comment by mdjbrown on Apr 05, 2024 2:47pm
I havent dug that deep yet alleyesonme, but trying to connect the dots based on public disclosure has been interesting.  We know Medipharm has an FDA approved CBD facility, but I am not sure if some of the other big name defendants also hold the same distinction. Trying to narrow it down though. “This was initiated in relation to MediPharm's Cannabidiol Active Pharmaceutical Ingredient  ...more  
Comment by subaru1i on Apr 05, 2024 5:09pm
mdjbrown...LABS as a CDMO for cananbis pharma API's, what if LABS is supplying the API's to TEVA and Apotex?  I don't see why that isn't possible....seems to me the FDA numbers you listed are close together and yes, they do issue those numbers in sequence.  
Comment by subaru1i on Apr 05, 2024 2:41pm
mdj...thank you very much for clearing that up for me.   I agree, Apotex is a strong candidate and their association with pharmaceutical(s) company in China definitely makes them a global player.   I personally include TEVA in my list as well simply because TEVA was doing cannabis research and development in Israel before Canada legalized.   
Comment by mdjbrown on Apr 05, 2024 3:03pm
you could be right s1i.  Teva appears to be the first defendant to file an ANDA with the FDA in the fall of 2022, if ANDA numbers are issued in numerical order when they are received by the FDA. Teva filed ANDA No. 217508 API Pharma filed ANDA No. 217522 Padagis filed ANDA No. 215865   (assume this is a misprint and should state 217865) Apotex filed ANDA No. 217699 Lupin filed ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities